Hyloris Pharmaceuticals SA (EBR:HYL)
Belgium · Delayed Price · Currency is EUR 4.200
-0.020 (-0.47%)
Sep 18, 2026, 5:09 PM CET
Hyloris Pharmaceuticals Market Cap
Hyloris Pharmaceuticals has a market cap or net worth of €117.6 million as of September 18, 2026. Its market cap has decreased by -31.15% in one year.
Market Cap
117.60M
Enterprise Value
105.44M
Revenue
7.94M
Ranking
n/a
PE Ratio
n/a
Stock Price
€4.20
ChartMarket Cap Chart
Since June 29, 2020, Hyloris Pharmaceuticals's market cap has decreased from 244.70M to 117.60M, a decrease of -51.94%. That is a compound annual growth rate of -11.11%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 117.60M | -38.60% |
| Dec 31, 2025 | 191.52M | 4.59% |
| Dec 31, 2024 | 183.12M | -48.71% |
| Dec 29, 2023 | 357.00M | 14.84% |
| Dec 30, 2022 | 310.88M | -30.44% |
| Dec 31, 2021 | 446.90M | 82.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| argenx SE | 54.50B |
| UCB SA | 39.68B |
| Financière de Tubize | 7.88B |
| Onward Medical | 201.29M |
| European Medical Solutions | 16.50M |
| Celyad Oncology | 10.74M |
| BioSenic | 1.31M |
| Oxurion NV | 309.62K |